Leverage Shares 2X Long AEHR Daily ETF (AEHG) is not an operating company but a single-stock leveraged exchange-traded fund listed on Cboe. It targets 200% of the daily percentage change in Aehr Test Systems, a Fremont, California-based maker of semiconductor test and burn-in systems used in silicon carbide power devices, silicon photonics and AI processors, minus fees and expenses of 0.99% annually.
Shares of AEHG were quoted at $1.695 on Monday, down $0.46 or 21.30%, against Friday's close of $2.16. The direction is unambiguously lower. The fund's decline tracks a 10.78% drop in AEHR, which fell from $56.98 to $50.84. No company-specific news release or filing from Aehr explained Monday's move; the driver was sector-wide.
The dominant force behind the liquidation was a broad retreat from AI-linked equities. Chip names led the decline: Micron Technology lost more than 6%, Intel and TSMC fell roughly 5% to 6%, Advanced Micro Devices slipped about 5%, and Broadcom shed around 4.5%. The Philadelphia Semiconductor Index dropped close to 5%, its weakest reading in a week.
Triggering the latest leg lower, a semiconductor research firm sharply cut its multi-year forecasts for AI accelerator shipments, capital spending, high-bandwidth memory demand and power requirements, with the deepest reductions falling in 2028 through 2030. That revision landed directly on the demand narrative that has powered burn-in and test equipment suppliers such as Aehr, whose order book depends on hyperscale customers building out AI infrastructure.
Sentiment was already fragile. Nvidia, which reports quarterly results on Tuesday, extended its worst weekly run since April 2025 following the departure of its chief executive, and new interim U.S. restrictions on advanced AI chip access to China added a policy overhang. Preparation for the Anthropic offering this week gave institutional investors another reason to trim high-beta technology exposure.
Aehr delivered a strong fiscal first-quarter 2027 report on November 2: revenue of $33.0 million, up about 201% year over year, GAAP net income of $7.2 million, non-GAAP earnings of $0.28 per share, bookings of $46.7 million and an effective backlog near $109.3 million. Management guided fiscal 2027 revenue to roughly $150 million.
The shares initially popped, then reversed hard. Sell-side firms trimmed targets even while keeping Buy ratings, with Jefferies moving to $140 from $175 and Lake Street to $90 from $110, and the stock has now given back most of the post-earnings gain. That distribution is a classic "sell the news" pattern in a name up more than 145% over 52 weeks, and it left AEHR trading well below its 50-day and 200-day moving averages.
Leverage then did the rest. Because AEHG resets exposure daily, a 10.78% underlying decline translated into a loss slightly larger than 21% before expenses, and the structure compounds losses in choppy markets. The fund has fallen from $22.31 in mid-August to under $1.70, a vivid illustration of volatility decay in a leveraged product held through a sustained downtrend.
The move was fully aligned with the semiconductor complex and diverged from the Dow, which was roughly flat, underscoring that this was a rotation out of AI beta rather than a broad risk-off event. Underlying Aehr turnover has actually run light during the slide, with recent sessions near 1.2 million to 1.6 million shares versus a three-month average closer to 2.8 million, a sign of thinning bids rather than panic-volume capitulation.
Technically, Aehr broke below its November 13 intraday low of $55.25 and the $50 area that had acted as a psychological floor, with the 50-day average near $78 now far overhead. For the ETF, the break of its recent range low near $2.03 confirmed the downtrend.
The score runs from 0 to 100, where 0 means no meaningful news and a move that is normal for the stock, and 100 means transformative news paired with an extreme, rare price move. This event scores 19 out of 100.
Verified news was weak relative to the fund's size: there was no company-specific announcement, only a sector-wide AI selloff and continued profit-taking after an already-public earnings beat. The price move was also unremarkable by this instrument's standards. It was about 1.9 times the ETF's typical absolute daily move of roughly 11.4% over the past 60 sessions, and 11 of those sessions produced equal or larger swings, including a 52.8% jump on November 3. Weak news plus a routine move for a highly volatile product produces a low score.
Attention now shifts to Nvidia's results on Tuesday evening, the single largest near-term swing factor for semiconductor sentiment and, by extension, for this fund. Aehr's next quarterly report is expected in late December or January, when investors will look for confirmation that the $150 million revenue target and the second hyperscale processor ramp remain on schedule.
Analyst consensus still sits at Buy with average targets well above the current share price, but dispersion has widened sharply. Risks include customer concentration, order timing slippage, a universal shelf registration that keeps potential dilution in view, and rising Treasury yields pressuring richly valued growth names. For AEHG specifically, path dependency matters: repeated daily resets in a volatile underlying can erode value even if Aehr shares merely move sideways.
Tickeron maintains hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions are surfaced in the curated Trending AI Robots section. The bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, making the page a practical starting point for comparing approaches during volatile stretches like this one. Visitors can review how individual strategies have behaved in the prevailing tape before deciding what to follow. Explore the Trending AI Robots page to see which automated strategies are leading right now.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.